Hemp vs CBD for Dogs: What's Actually in the Product and Why It Matters
Last reviewed · Citation policy
Hemp seed oil and CBD oil come from the same plant but are chemically, legally, and functionally different. What peer-reviewed research and regulatory bodies say about each, and why the distinction matters for canine health.
Published
2023
Updated
2023
References
7 selected
Same plant, different product
Hemp seed oil and CBD oil both come from Cannabis sativa L., the hemp plant. That is where the similarity ends. They are extracted from different parts of the plant, contain different compounds, are regulated differently, and have different biochemical profiles.
The labeling confusion is understandable — product labels say "hemp" for both. But from a chemistry, safety, and regulatory standpoint, they are distinct products with distinct profiles.
| Hemp seed oil | CBD oil | |
|---|---|---|
| Source | Cold-pressed from the seeds | Extracted from flowers, leaves, and stalks |
| Active compounds | Omega-3, omega-6, GLA, vitamin E | Cannabidiol (CBD), minor cannabinoids, terpenes |
| Cannabinoid content | Trace only (pharmacologically irrelevant) | 15,000–60,000 µg/mL CBD typical |
| FDA status | GRAS for human food (2018); widely used in pet products | Not approved for animal use |
| Available on Amazon | Yes | No (prohibited for pet supplements) |
| How to identify | No CBD milligram content listed | CBD content listed in mg per serving |
Key takeaway
If a product does not list CBD content in milligrams on the label, it is likely a hemp seed product, not a CBD product. Watch for "hemp extract" labels, which may contain cannabinoids. The two categories have different compounds, different safety profiles, and different regulatory status.
Hemp seed safety profile
In December 2018, the FDA responded to three GRAS (Generally Recognized as Safe) notices for hemp seed ingredients used in human food: hulled hemp seeds (GRN 765), hemp seed protein powder (GRN 771), and hemp seed oil (GRN 778). The agency had "no questions" about their safety for the intended uses described.
These GRAS determinations were specifically for human food, not pet products. However, hemp seed oil is commonly used in pet supplements without the regulatory concerns that accompany CBD products. The GRAS status reflects the ingredient's established safety profile even if the formal determination does not extend to animal products.
What about trace cannabinoids in hemp seeds?
A 2019 analytical study (Choi et al.) found hemp seeds contain THC at 0.06–5.91 µg/g and CBD at 0.32–25.55 µg/g. These traces come from incidental contact between seeds and the cannabinoid-producing parts of the plant during harvesting, not from the seeds themselves.
For context, CBD oils for dogs typically contain CBD concentrations orders of magnitude higher. The trace amounts detected in hemp seeds are below any known pharmacological threshold and are considered clinically insignificant.
No documented liver enzyme effects. Hemp seed oil has not been associated with the ALP elevations seen with CBD in published studies, though systematic liver-enzyme monitoring data specific to hemp seed oil in dogs are limited.
No documented drug interactions. Because hemp seed oil does not contain pharmacologically relevant cannabinoids, it is not expected to inhibit cytochrome P450 enzymes the way CBD does. However, formal drug interaction studies for hemp seed oil in dogs have not been published.
No meaningful psychoactive potential. The trace cannabinoid levels in hemp seed oil are far below any known psychoactive threshold.
Key takeaway
Hemp seed ingredients have FDA GRAS determinations (for human food) and are widely used in pet products. They lack the cannabinoid content associated with liver enzyme changes and drug interactions seen with CBD. The trace cannabinoids present from processing are orders of magnitude below the levels in CBD products.
Why some owners avoid CBD
Surveys suggest that while roughly half of pet owners express interest in CBD, far fewer have actually tried it. That gap represents real hesitancy, and the reasons are documented in the research.
Liver enzyme changes
Documented in the Cornell osteoarthritis study.
The 2018 Cornell study found that CBD at 2 mg/kg twice daily (PMCID: PMC6065210) significantly elevated alkaline phosphatase (ALP) in a majority of study dogs within four weeks. The elevations were reversible after discontinuation, but dogs on other medications or with liver conditions may face greater risk. This is the most evidence-based reason for caution with CBD.
Drug interactions
CBD affects cytochrome P450 metabolism.
CBD inhibits several cytochrome P450 enzymes in the liver. These enzymes metabolize many common veterinary medications including NSAIDs, certain heart medications, and anti-seizure drugs. For dogs already on medication, this interaction is a legitimate concern documented in the literature.
Regulatory uncertainty
The FDA has not approved any CBD product for animals.
The FDA has not approved CBD for any use in animals and continues to issue warning letters to companies making therapeutic claims about CBD pet products. Survey data suggest many veterinarians feel uncomfortable discussing cannabinoid use with clients, partly due to these regulatory constraints.
Product quality concerns
The unregulated CBD market produces wide variation in potency and purity.
The unregulated nature of the CBD market means potency, purity, and labeling accuracy vary widely. Independent testing has found CBD products that contain more or less CBD than labeled, and some that contain detectable THC despite "THC-free" claims.
These concerns are tied to cannabinoid activity. The full CBD guide covers the evidence in detail for those who want to evaluate CBD on its own terms.
Key takeaway
The concerns associated with CBD — liver enzyme changes, drug interactions, regulatory uncertainty, quality variability — are tied to cannabinoid activity. Hemp seed oil lacks pharmacologically relevant cannabinoids, so these specific concerns are not expected to apply.
Regulatory status
The regulatory gap between hemp seed products and CBD products is wide. Understanding it explains why these products are treated so differently by retailers, veterinarians, and platforms.
Hemp seed ingredients
- FDA GRAS since 2018. Hulled hemp seeds, hemp seed protein, and hemp seed oil all received "no questions" GRAS determinations (GRN 765, 771, 778).
- AAFCO ingredient definition (limited scope). In August 2024, AAFCO adopted a tentative definition for mechanically extracted hempseed meal for laying hen feed, with strict cannabinoid limits. This was the first species-specific approval and does not yet extend to dog food, but signals the direction of regulatory acceptance.
- Widely available at retail. Hemp seed products sell on Amazon, Chewy, Walmart, and other major pet retailers without the platform restrictions that apply to CBD.
- No known FDA enforcement actions. Unlike CBD pet products, hemp seed oil products have not been the subject of FDA warning letters.
CBD products
- Not FDA approved for animals. No CBD product has received FDA approval for any use in any animal species.
- Active enforcement. The FDA has issued warning letters to pet CBD companies for marketing unapproved animal drugs, and continues to do so.
- Prohibited on Amazon for pet products. Amazon's seller policy prohibits CBD pet supplements regardless of THC content or state legality.
- State-by-state variability. CBD legality and veterinary guidance vary by state, creating additional uncertainty for both consumers and professionals.
Key takeaway
Hemp seed ingredients have FDA GRAS determinations for human food and an AAFCO feed ingredient definition (currently for poultry). CBD products have neither. The regulatory gap reflects the different risk profiles of these two ingredient categories.
What calming products actually contain
Many popular calming supplements use hemp seed as a nutritional ingredient alongside active calming compounds. These are not CBD products. In these formulations, hemp seed serves as a nutritional base providing omega fatty acids, while the calming effect comes from amino acids (L-theanine, L-tryptophan), botanicals (valerian, chamomile, passionflower), and in some cases melatonin.
| Product | Hemp ingredient | Calming actives |
|---|---|---|
| PetHonesty Hemp Calming Max Strength | Hemp | L-theanine (Suntheanine), chamomile, valerian root, melatonin, ginger |
| Zesty Paws Calming Bites | Organic hemp | L-theanine (Suntheanine), valerian root, chamomile |
These products are cited as illustrative examples of the hemp seed-based calming supplement category. They are not cited in the research above and their inclusion is not an endorsement of specific products.
Terminology inconsistency in pet hemp products
Labeling practices in the pet hemp product market are inconsistent. A label reading "hemp seed oil," "hemp seed powder," or "hemp hearts" with no CBD milligram amount indicates a seed-derived nutritional product. A label listing CBD content in milligrams per serving — or using "hemp extract," "whole-plant extract," or "THC-removed extract" — indicates a cannabinoid product.
Note: some cannabinoid products use "hemp extract" or "THC-removed hemp" without a clear CBD milligram amount. When those terms appear, a certificate of analysis (COA) or manufacturer confirmation is needed to determine what the product actually contains. The absence of CBD milligram disclosure is not, by itself, confirmation that the product is cannabinoid-free.
Key takeaway
The most popular calming supplements on the market use hemp seed as a nutritional ingredient, not as a source of CBD. The calming compounds are amino acids, botanicals, and melatonin.
Nutritional value of hemp seed
Hemp seed oil is not an anxiolytic. It does not support calm behavior in dogs the way L-theanine or melatonin can. But it is a nutritionally dense ingredient that contributes omega fatty acids to overall wellness.
Omega fatty acid balance
3:1 ratio of omega-6 to omega-3.
Hemp seed oil provides omega-6 and omega-3 fatty acids in a ratio often cited as favorable (approximately 3:1). An 18-week pilot study found that omega-3 supplementation (combined with magnesium and zinc) significantly reduced fearfulness and destructiveness scores in dogs with behavioral disorders.
A separate study found that aggressive dogs had significantly lower omega-3 levels and higher omega-6/omega-3 ratios compared to non-aggressive dogs, suggesting that fatty acid status may influence behavioral regulation.
Gamma-linolenic acid (GLA)
Anti-inflammatory omega-6 found in few dietary sources.
Hemp seed oil is one of the few dietary sources of GLA, an omega-6 fatty acid with anti-inflammatory properties. GLA converts to DGLA (dihomo-gamma-linolenic acid), which competes with pro-inflammatory pathways. The relationship between GLA supplementation and canine anxiety has not been directly studied, but the anti-inflammatory properties of GLA are well-documented.
Skin and coat support
Widely recognized by veterinary professionals.
The balanced omega profile in hemp seed oil supports skin hydration and coat quality. This is one of the most widely recognized nutritional benefits of hemp seed oil for dogs.
Key takeaway
Hemp seed oil is not a calming drug. It contributes omega fatty acids to overall wellness. Research links omega-3 status to behavioral outcomes in dogs, but direct anxiolytic claims about hemp seed oil itself would overstate the evidence.
Evidence gaps and formulation considerations
The distinction between hemp seed oil and CBD reflects different research histories. Hemp seed's role in calming supplements is nutritional, not pharmacological — this is a gap between how these products are often marketed and what the literature supports.
Cannabinoid-avoidant formulations: Hemp seed products contain only trace cannabinoids from incidental processing contact, far below any known pharmacological threshold. The published literature does not support a meaningful cannabinoid effect from hemp seed oil.
Cytochrome P450 considerations: Hemp seed oil is not expected to share CBD's cytochrome P450 interaction profile, as pharmacologically relevant cannabinoids are absent. No formal drug interaction studies for hemp seed oil in dogs have been published, so this remains an extrapolation rather than a confirmed finding.
Distinction from veterinary CBD concerns: The reasons documented in the literature for CBD caution — cannabinoid interactions, ALP elevations — are generally unrelated to hemp seed oil. Whether veterinary CBD advisories extend to hemp seed products depends on the specific concern being addressed. Confirmation of the scope of such guidance is appropriate in individual cases.
Omega-3 and behavior: The research linking omega-3 status to behavioral outcomes in dogs was conducted with fish oil and structured omega-3 supplementation, not hemp seed oil specifically. Extrapolating those findings to hemp seed is plausible given the fatty acid profile, but not directly supported by hemp-seed-specific behavioral trials.
For further context on the cannabinoid evidence, the CBD evidence guide covers what the research actually says, including both the promising findings and the limits.
Key takeaway
The evidence base for hemp seed oil in canine anxiety is nutritional, not pharmacological. Direct anxiolytic trials on hemp seed oil in dogs have not been conducted; its role in calming supplements is as a fatty-acid contributor alongside clinically studied actives. Cannabinoid-specific concerns documented for CBD are not expected to apply.
Evidence-based guidance
Scout uses the evidence on ingredient-class distinctions — what hemp seed provides versus what CBD provides — to match supplement recommendations to a dog's specific anxiety type and history, rather than relying on marketing category. Talk to Scout
How this guide connects to the Pawsd knowledge base
The hemp-versus-CBD page keeps Scout tied to ingredient chemistry, regulatory context, and interaction risk rather than front-label claims. Hemp seed oil and CBD oil are not interchangeable anxiety tools. Dogs on medication or showing severe distress should be discussed with a veterinarian before supplements change.
Frequently asked questions
Does hemp seed oil contain CBD?
Only in traces. Analytical studies detect CBD at 0.32–25.55 µg/g in hemp seeds, which is orders of magnitude below the concentrations found in CBD products. These trace amounts are considered pharmacologically irrelevant.
Is hemp seed oil safe for dogs?
Hemp seed ingredients received FDA GRAS determinations for human food in December 2018 and are widely used in pet products. Veterinary professionals generally recognize hemp seed oil as a safe nutritional supplement. Because it lacks pharmacologically relevant cannabinoids, it is not expected to share the drug interaction or liver enzyme concerns associated with CBD, though formal canine-specific studies are limited.
Can hemp seed products be purchased through mainstream retail channels?
Yes. Amazon prohibits CBD pet supplements but allows hemp seed oil and hemp seed powder products. Many popular calming supplements use hemp seed as a nutritional ingredient and are available on major retail platforms, unlike CBD pet products, which are prohibited under Amazon's seller policy.
Does hemp seed oil have anxiolytic properties in dogs?
Hemp seed oil alone is not a sedative or anxiolytic. It provides omega-3 and omega-6 fatty acids and GLA, which support overall wellness and inflammatory balance. In calming supplements, hemp seed typically appears alongside active calming ingredients like L-theanine, melatonin, and valerian root. The calming effect comes from those ingredients, not from the hemp seed itself.
What distinguishes hemp seed oil from CBD oil at the chemical level?
Hemp seed oil is cold-pressed from the seeds and contains fatty acids and minerals but essentially no cannabinoids. CBD oil is extracted from the flowers and leaves where cannabinoids concentrate. If a product does not list CBD content in milligrams, it is likely a hemp seed product, though labels saying "hemp extract" may still contain cannabinoids.
Does hemp seed oil require veterinary disclosure before use?
Hemp seed oil is generally less likely to raise clinical concerns than CBD because it lacks the cannabinoid content associated with drug interactions and liver enzyme changes documented in the literature. Informing a veterinarian about any new supplement is generally appropriate practice, particularly for dogs on concurrent medications.
Evidence-informed article
Pawsd Knowledge articles are educational and not a substitute for veterinary advice. These pages draw from selected open-access peer-reviewed veterinary research, with full-text sources linked below.
Selected references
Front Plant Sci. 2019;10:120. Open-access analytical study on cannabinoid content in hemp seed oil.
Food Sci Biotechnol. 2019;28(6):1839–1844. PMID: 31786513. Quantitative analysis of cannabinoids in hemp seed products.
Front Vet Sci. 2018;5:165. PMCID: PMC6065210. Cornell study documenting liver enzyme elevation with CBD use in dogs.
J Vet Behav. 2018;27:14–20. Pilot study showing omega-3 supplementation reduced fearfulness scores in dogs.
J Vet Intern Med. 2007;21(1):6. PMID: 17891468. Study linking low omega-3 levels to behavioral disturbance in dogs.
Int J Mol Sci. 2022;23(14):7615. PMCID: PMC9312346. Open-access study on nutritional intervention and anxiety-linked metabolites.
Front Vet Sci. 2023;10:1204526. PMCID: PMC10347378. Open-access review of CBD safety data in dogs.
Related Reading
Acepromazine for Dog Anxiety: Sedation, Fear, and Modern Vet Use
A veterinary-boundary guide to acepromazine for dog anxiety questions, explaining sedation without anxiety relief, noise-fear concerns, historical use, monitoring issues, and modern alternatives.
Dog-Appeasing Pheromone (DAP): Efficacy and Evidence Review
An evidence-based review of dog-appeasing pheromone (DAP) efficacy, vomeronasal processing mechanisms, and clinical limitations in canine behavioral therapy.
Alpha-Casozepine for Dogs: Calming Supplement Evidence and Limits
An evidence-reference guide to alpha-casozepine for dogs, covering proposed GABA-A mechanisms, calming-supplement use, canine evidence limits, combination-product caveats, and when prescription care is more appropriate.
The First Week After Adopting a Dog: Physiological and Behavioral Adjustment
Shelter dogs arrive with elevated physiological stress markers that require time to down-regulate. This guide examines what the research shows about the adjustment arc in newly adopted dogs: the physiological baseline at adoption, the 3-3-3 framework for behavioral adjustment, how schedule predictability reduces arousal, the case for introducing alone time early, and what adopter expectation surveys document about the gap between expected and experienced outcomes.
© 2026 Pawsd LLC. All rights reserved. The selection, arrangement, and original commentary in this guide are the copyrighted work of Pawsd. While the underlying research is publicly available, the editorial analysis, evidence curation, and breed-specific guidance reflect original work. Reproduction or redistribution of this material without written permission is prohibited. For licensing inquiries, contact hello@pawsd.ai.